Light-activated photodynamic compounds from Theralase destroy E. coli bacteria

Sept. 15, 2011
Toronto, ON, Canada--Theralase Technologies' Photo Dynamic Compounds can destroy Escherichia coli, commonly known as the disease-causing bacteria E. coli.

Toronto, ON, Canada--After its announcement late last year that its photodynamic compounds work with light to destroy listeria bacteria, Theralase Technologies just reported that those compounds can also destroyEscherichia coli, commonly known as E. coli, a widely prevalent disease causing bacteria. Theralase, who designs, develops, manufactures, and markets patented superpulsed laser technology utilized in biostimulation and biodestruction applications, says its patented Photo Dynamic Compounds (PDCs) can be activated with light to destroy a host of harmful bacteria in clinical settings.

E. coli is one of the top four pathogens causing Healthcare Associated Infections (HAIs), and the U.S. Centers for Disease Control and Prevention estimates that HAIs have led to $45 billion in healthcare costs annually and have resulted in nearly 100,000 deaths per year, making HAIs the fourth leading cause of death.

Arkady Mandel, chief scientific officer at Theralase, said, "Our research has repeatedly demonstrated that our Photo Dynamic Therapy (PDT) destruction of E. coli bacteria is effective and represents a significant opportunity in the area of disinfection and sterilization of bacterial pathogens that may cause serious and potentially life-threatening illness."

Roger Dumoulin-White, president and CEO of Theralase, added, "We are encouraged that our patented Photo Dynamic Compounds (PDCs) are proving effective in so many varied applications. Not only are these PDCs being shown to be effective in the destruction of cancer cells, but now they are also being shown to be effective in the destruction of various types of bacteria, including Listeria and E. coli. Commercialization of these technologies becomes more and more apparent, as our research and development progresses, allowing us the opportunity to introduce these technologies to the world in a variety of diverse applications."

SOURCE: Theralase; www.theralase.com/press/Theralase_Achieves_Success_in_Destruction_of_E__Coli_4.pdf

Posted by:Gail OvertonSubscribe now to Laser Focus World magazine; It’s free! Follow us on Twitter Follow OptoIQ on your iPhone. Download the free App here

Sponsored Recommendations

Electroplating 3D Printed Parts

Jan. 24, 2025
In this blog post, you'll learn about plating methods to enhance the engineering performance of resin micro 3D printed parts.

Hexapod 6-DOF Active Optical Alignment Micro-Robots - Enablers for Advanced Camera Manufacturing

Dec. 18, 2024
Optics and camera manufacturing benefits from the flexibility of 6-Axis hexapod active optical alignment robots and advanced motion control software

Laser Assisted Wafer Slicing with 3DOF Motion Stages

Dec. 18, 2024
Granite-based high-performance 3-DOF air bearing nanopositioning stages provide ultra-high accuracy and reliability in semiconductor & laser processing applications.

Steering Light: What is the Difference Between 2-Axis Galvo Scanners and Single Mirror 2-Axis Scanners

Dec. 18, 2024
Advantages and limitations of different 2-axis light steering methods: Piezo steering mirrors, voice-coil mirrors, galvos, gimbal mounts, and kinematic mounts.

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!